In a monumental achievement for global public health, the World Health Organization (WHO) has officially validated Algeria as having eliminated trachoma—the world’s leading infectious cause of blindness—as a public health problem. This landmark status makes Algeria the 10th country in the WHO African Region and the 29th nation globally to reach this milestone, marking a definitive turning point in the country’s century-long struggle against this debilitating neglected tropical disease (NTD).
The announcement serves as a testament to the power of sustained political will, robust infrastructure, and the relentless dedication of generations of Algerian health professionals. As the world continues to grapple with the burden of NTDs, Algeria’s success provides a scalable blueprint for nations currently striving to eradicate infectious diseases that disproportionately affect the most vulnerable populations.
Understanding the Enemy: The Nature of Trachoma
Trachoma is far more than a simple eye infection; it is a chronic, painful, and potentially blinding condition caused by the bacterium Chlamydia trachomatis. The disease is highly contagious and spreads through direct contact with an infected person’s eye or nose discharge, often transmitted by contaminated fingers, clothing, or even swarms of flies.
The cycle of infection is insidious. Repeated episodes of the disease lead to severe scarring on the inner side of the upper eyelid. As this scar tissue contracts, it pulls the eyelashes inward—a agonizing condition known as "trachomatous trichiasis" (TT). In this state, the eyelashes scrape against the cornea with every blink, causing chronic pain, irreversible corneal scarring, and eventually, permanent blindness.
Globally, the statistics remain sobering. Trachoma is still endemic in 30 countries, leaving approximately 97 million people living in areas where they are at risk of infection. The disease is responsible for the visual impairment or total blindness of roughly 1.9 million people worldwide, trapping many in a cycle of poverty and reduced economic productivity. By eliminating the disease, Algeria has not only saved the eyesight of thousands but has also removed a significant barrier to the socio-economic development of its southern provinces.
A Century of Dedication: The Chronology of Elimination
Algeria’s journey to this moment did not happen overnight; it is the culmination of over a hundred years of institutional commitment and public health evolution.
The Foundation (1909–1960s)
The fight began with the establishment of the Pasteur Institute of Algeria in 1909, which laid the initial groundwork for infectious disease control. Following the nation’s independence, the mission gained new momentum under the visionary leadership of Professor Mohamed Aouchiche. Recognizing the magnitude of the ocular health crisis, Aouchiche and his colleagues championed a systematic approach to identifying and treating the disease.
The Turning Point (1974)
A critical shift occurred in 1974, when the Algerian government integrated eye care into a newly formed national public healthcare system. By providing services free of charge, the state ensured that the most marginalized populations in rural areas gained access to medical intervention, effectively democratizing the battle against trachoma.
The Accelerated Phase (2013–2015)
To clear the final hurdles, the Ministry of Health launched an aggressive three-year national strategy (2013–2015). A National Expert Committee was established to oversee the implementation of the WHO-recommended "SAFE" strategy, specifically targeting 12 southern wilayas (provinces) where the disease remained entrenched, including Adrar, Tamanrasset, Ghardaïa, and Tindouf.
The Validation (2022–2025)
In 2022, rigorous, WHO-compliant surveys were conducted across the previously affected regions. While the elimination threshold for active trachoma was met nationwide, the survey identified three specific areas where the TT threshold required additional effort. Algeria’s health authorities responded immediately, launching door-to-door screening and surgical management campaigns to close the gap. By December 2025, the Ministry of Health submitted a comprehensive dossier to the WHO, documenting the evidence required to validate the nation as trachoma-free.
The Strategy: Implementing the WHO "SAFE" Protocol
Algeria’s victory was anchored by the comprehensive application of the WHO-endorsed SAFE strategy, a multifaceted approach designed to tackle the disease from every angle:
- Surgery: The government invested heavily in training and deploying surgeons to treat existing cases of trachomatous trichiasis, preventing the progression to blindness in those already scarred by the infection.
- Antibiotics: Mass administration of antibiotics was conducted in endemic pockets to clear the Chlamydia trachomatis infection from the population.
- Facial Cleanliness: Large-scale public awareness campaigns were launched to educate citizens on the importance of hygiene and the role of facial cleanliness in breaking the transmission chain.
- Environmental Improvement: Perhaps most significantly, the government prioritized the improvement of access to clean water and sanitation. By reducing the reliance on unsafe water sources and improving hygiene infrastructure, Algeria fundamentally altered the environment that allowed the bacterium to thrive.
Official Responses: A Collective Triumph
The significance of this milestone was underscored by leaders from across the global health community.
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, lauded the achievement, stating: "Algeria’s elimination of trachoma is a historic triumph that connects the past, present, and future of public health. This milestone proves that with sustained political will and on-the-ground leadership from committed health professionals, we can eliminate neglected tropical diseases and build a healthier, more resilient future for all."
Dr. Mohamed Janabi, WHO Regional Director for Africa, emphasized the human impact of the success. "Trachoma devastates individuals and communities profoundly. The milestone by Algeria is a major achievement that transforms the health and well-being of children, women, and entire families. It demonstrates that eliminating neglected tropical diseases is possible with consistent and coordinated efforts."
Professor Mohamed Seddik Ait Messaoudene, the Minister of Health of Algeria, framed the victory as a testament to national unity. "This achievement represents a collective victory—the fruit of nearly fifty years of national mobilization. It attests to our country’s capacity to meet the most rigorous public health standards—standards grounded in prevention, equitable access to care, and the improvement of living conditions."
Implications for the Future: Sustainability and Beyond
While the WHO has officially validated Algeria as having eliminated the disease, the work is far from over. Elimination does not mean that the bacterium has been permanently eradicated from the planet; rather, it means that it is no longer a public health threat within Algeria’s borders.
To prevent a resurgence, the WHO is currently working with Algerian health authorities to implement a robust post-validation surveillance program. This monitoring will keep a close eye on formerly endemic populations, ensuring that if any new cases arise, they are treated rapidly to prevent a wider outbreak.
A New Benchmark for Neglected Tropical Diseases
The impact of this news extends far beyond the borders of Algeria. Neglected tropical diseases (NTDs) represent a group of 21 conditions that affect over one billion people worldwide, primarily in impoverished tropical areas. By becoming the 62nd country globally—and the 23rd in the African Region—to eliminate at least one NTD, Algeria has set a new benchmark for what is possible within the "2021–2030 Road Map for Neglected Tropical Diseases."
The success also highlights the importance of multisectoral coordination. The involvement of the school health system, the integration of health information systems, and the broader development of water and sanitation infrastructure were as essential to the victory as the medical interventions themselves.
As the international community looks toward 2030, Algeria’s experience serves as a powerful reminder: the elimination of infectious diseases is not merely a medical challenge, but a social and political one. By investing in the health of the most vulnerable and maintaining a vision that spans decades rather than election cycles, nations can fundamentally reshape their public health landscape. For Algeria, the path forward is clear: building on this foundation to ensure that the health and dignity of its people remain at the heart of its national agenda.
About the Author
